Medherant Ltd.
Adhesive patch for transdermal drug delivery
This article was originally published in Start Up
Executive Summary
Medherant Ltd. 's drug delivery patch technology can accommodate medium or low potency drugs at a suitable saturation level to permeate the skin but without compromising adhesion, which existing patch technology has failed to achieve. This means that low potency drugs such as ibuprofen – the company's first product – can now be formulated into a patch rather than only being available in topical gel or cream.